Release of Accolade version 13.2
05/11/2020 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201105:nRSE2979Ea
RNS Number : 2979E Sopheon PLC 05 November 2020
SOPHEON PLC
("Sopheon" or the "Company")
New Sopheon Release improves Speed to Make Informed Decisions
New enhancements turn data into information, give confidence in resourcing
plans & dynamically align functions across the company
Sopheon, the international provider of software, expertise and best practices
for enterprise innovation management
(https://www.sopheon.com/?utm_source=PressRelease&utm_medium=Press&utm_campaign=PR-Gen)
, today announces the release of Accolade® version 13.2.
The COVID-19 crisis with its massive impact on companies and industries will
have lasting effects on business, many of which are as yet unknown. As
companies deal with pandemic-related delays - planned or unplanned - and
initiate strategic pivots, it is naturally tempting to jump from one urgent
task to the next, to just execute in the hope of staying the course.
Manufacturers are rapidly bringing supply chains home to rectify mass
disruption of access to materials and distribution channels; consumer products
companies are changing their product portfolio mix and increasingly shifting
to direct-to-consumer sales models; companies across all industries are
rationalizing their product mix, cutting the breadth of offerings in order to
meet unexpected demand for certain elements of their portfolios.
The capabilities released today in Accolade 13.2 are designed to help
companies prioritize the most pressing issues first while ignoring
distractions; and to get interactive data visualizations that enable informed
decision making by providing a faster path to uncovering critical insights.
This will assist business leaders in taking immediate action, rapidly
assessing impacts of decisions, and mitigating the risks to their business,
product and operational plans, and resources.
"The ability to engage interactively with our data and manipulate it in situ
is exciting," said Dave MacAdam, Director of Innovation Strategy at Novelis,
"This will help both our business leaders and technical users gain immediate
answers to their questions, which will dramatically increase the speed to
decisions. The value of this is enormous."
For further information contact:
Barry Mence (Chairman) Sopheon plc + 44 (0) 1276 919 560
Arif Karimjee (CFO)
Carl Holmes/Giles Rolls (Corporate Finance) finnCap Ltd + 44 (0) 20 7220 0500
Alice Lane (ECM)
About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete
enterprise innovation management
(https://www.sopheon.com/?utm_source=PressRelease&utm_medium=Press&utm_campaign=PR-Gen)
solutions including software, expertise, and best practices, that enable them
to achieve exceptional long-term revenue growth and profitability. Sopheon's
Accolade solution provides unique, fully-integrated coverage for the entire
innovation management and new product development lifecycle, including
strategic innovation planning, roadmapping, idea and concept development,
process and project management, portfolio management and resource planning.
Sopheon's solutions have been implemented by over 250 customers with over
60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the
London Stock Exchange. For more information, please visit www.sopheon.com
(http://www.sopheon.com) .
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAFSAFWLESSESF